We make novel antibody medicines to treat cancers and rare diseases.
- Project: [page_title] & BTI. Proof of concept of the efficacy. Design of experiments using ONENA additive combined with PRGF in term of cell proliferation.
Articles related with [page_title]
2626/09/2018
Bind 4.0’s 2018 Roadshow
This year Bind 4.0 has toured Europe to explain its acceleration program to startups in different European cities. We have been to Berlin and Hannover (Germany), London (UK), Lisbon (Portugal), Bayonne (France), Charleroi (Belgium), Barcelona, Santiago and Madrid (Spain). […]
2222/09/2018
More than 500 Startups have applied to the Third Edition of Bind 4.0
A total of 524 startups have applied to the third edition of Bind 4.0’s acceleration program, around 36% more than last year. They come from 63 different countries, with Spain, India, USA, Israel, UK and Germany holding the largest representations. […]
